Leadership: Page 15


  • This week's Woman of the Week Michelle Marlborough of AiCure shares her journey and leadership lessons.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Replimune CEO and co-founder Philip Astley-Sparke
    Image attribution tooltip
    Permission granted by Replimune/Philip Astley-Sparke
    Image attribution tooltip

    Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

    Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

    By Alexandra Pecci • May 9, 2022
  • drug shopping cart Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • This week's Woman of the Week Dr. Jane Parnes of Amgen, shares her R&D journey and leadership lessons.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Amgen's Dr. Jane Parnes

    As executive medical director, early development at Amgen, Dr. Jane Parnes has helped guide clinical research for upwards of 30 of the company’s investigational molecules, including the newly approved Tezspire for severe asthma — one of her career highlights.

    By May 4, 2022
  • Headshot of Nelson Ambrogio.
    Image attribution tooltip

    Permission granted by Nelson Ambrogio.

    Image attribution tooltip
    Profile

    Bayer executive makes strides toward a finish line for rare cancers

    Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.

    By Alexandra Pecci • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By May 2, 2022
  • This week's Woman of the Week Dr. Shanthi Ganeshan of Gilead shares how she is championing regulatory affairs as a way to move the needle.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Gilead Science's Dr. Shanthi Ganeshan

    As vice president of Global Regulatory Affairs, Oncology at Gilead, Ganeshan says there’s ‘never a dull moment’ in the quest to deliver therapies to patients.

    By April 27, 2022
  • White mouse in laboratory
    Image attribution tooltip
    D-Keine via Getty Images
    Image attribution tooltip
    Profile

    Mouse vs. machine: Using AI to solve the animal testing model in pharma

    Quris is bringing its first drug tested preclinically using AI — rather than animal models — into human trials.

    By April 26, 2022
  • This week's Woman of the Week Dr. Elisabet de los Pinos shares her life-long ambition to cure cancer in an innovative way
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Aura Biosciences' Dr. Elisabet de los Pinos

    Dr. Elizabet de los Pinos, CEO and founder of Aura Biosciences, had a dream at a young age to change the course of cancer treatment and understand the underlying DNA of the disease.

    By April 20, 2022
  • Entos Chief Medical Officer Steve Chen
    Image attribution tooltip
    Permission granted by Entos/Steve Chen
    Image attribution tooltip
    Profile

    With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential

     Steve Chen is helping to lead Entos through an ‘inflection point’ in the development of its precision medicine delivery platform.

    By Alexandra Pecci • April 14, 2022
  • Busy traffic in Downtown Los Angeles at dusk.
    Image attribution tooltip
    Yongyuan via Getty Images
    Image attribution tooltip
    Q&A

    Biotech goes Hollywood

    A few years ago, the biotech venture world in LA was almost ‘nonexistent’ — now Joseph Panetta, CEO of Biocom California, says the region is undergoing a major change.

    By April 13, 2022
  • Image attribution tooltip
    Kenny Holston via Getty Images
    Image attribution tooltip

    Why the war in Ukraine could accelerate the deglobalization of clinical trials

    COVID-19 slowed many studies — but the war could further strain clinical trials worldwide.

    By April 12, 2022
  • This week's Woman of the Week Liz Homans shares how her career journey has led to this transformational moment in cancer therapeutics
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Lyell Immunopharma's Liz Homans

    The CEO has the company poised to capitalize on its moment to address T cell exhaustion.

    By April 6, 2022
  • Roche Pharmaceutical Group's office building in Shanghai, China
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    A planned trial revives a glimmer of hope for a Huntington's disease treatment

    Roche brought a Huntington’s drug back to life after a jarring trial halt.

    By Kelly Bilodeau • April 6, 2022
  • Alnylam Pharmaceuticals CEO Yvonne Greenstreet
    Image attribution tooltip
    Permission granted by Alnylam/Yvonne Greenstreet
    Image attribution tooltip
    Profile

    Seeing yourself at the top: Alnylam CEO on why representation matters

    Dr. Yvonne Greenstreet became just the sixth woman in the world to head up a biopharma company with a market cap of more than $5 billion when she took on the role of CEO in January.

    By Alexandra Pecci • April 6, 2022
  • Apurva Saraf Headshot
    Image attribution tooltip

    Permission granted by Apurva Saraf. 

    Image attribution tooltip

    An analyst turned pharma CEO learns the art of operations

    Under Apurva Saraf’s guidance, Cosette Pharmaceuticals is pivoting wholeheartedly into the cardio space.

    By Jared Whitlock • April 5, 2022
  • Image attribution tooltip
    Real Chemistry/PharmaVoice
    Image attribution tooltip
    Q&A

    Lessons from improv: Shankar Narayanan’s ‘yes, and’ approach to healthcare leadership

    Real Chemistry's CEO is bringing a unique set of skills to the role as he sets off on a company-wide listening tour.

    By April 4, 2022
  • Image attribution tooltip

    Sangamo Therapeutics

    Image attribution tooltip
    Q&A // Biotech Spotlight

    Sangamo has its finger on the next evolution of gene editing

    Sangamo Therapeutics' CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.

    By March 31, 2022
  • This week's Woman of the Week Sabrina Martucci Johnson shares how she is looking to transform women's health
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

    The CEO is setting a path to transform women’s health at an opportune time.

    By March 30, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Merck's Dr. Mary-Ann Etiebet

    The associate VP of health equity is on a quest to address the relationship between health, gender and economic opportunities.

    By March 23, 2022
  • Image attribution tooltip
    Retrieved from PharmaVOICE on March 21, 2022
    Image attribution tooltip
    Q&A

    BioMarin’s new global head of advocacy is tackling the holy grail of patient engagement

    In her new role, Dr. Roz is keeping her patient-first approach.

    By March 21, 2022
  • Image attribution tooltip

    Permission granted by Anthony Mack.

    Image attribution tooltip

    Virpax's CEO on leveraging new formulations to move drugs toward approval

    Anthony Mack shares his lessons from getting unconventional pharma products across the finish line.

    By March 18, 2022
  • Image attribution tooltip

    Novartis' manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. Permission granted by Novartis.

    Image attribution tooltip
    Q&A

    How Novartis kept its supply chain intact during COVID-19

    In an agile pivot, Amit Nastik led Novartis’ manufacturing operations through the pandemic without losing supply chain reliability. 

    By March 16, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi

    Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health. 

    By March 16, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Terry Weber
    Image attribution tooltip
    Q&A

    Biote CEO: Employers need to normalize women's health issues in the workforce

    A survey by Biote reveals the impact of menopause on working women.

    By Robin Robinson • March 14, 2022
  • Image attribution tooltip

    Permission granted by Russell Potterfield.

    Image attribution tooltip
    Profile

    From angel to operator: The unlikely journey of Endevica Bio's CEO

    Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.

    By Jared Whitlock • March 9, 2022